🇺🇸 Subperiosteal 1:100.000 Articaine 4% epinephrine in United States

Subperiosteal 1:100.000 Articaine 4% epinephrine (Subperiosteal 1:100.000 Articaine 4% epinephrine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Subperiosteal 1:100.000 Articaine 4% epinephrine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Subperiosteal 1:100.000 Articaine 4% epinephrine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Subperiosteal 1:100.000 Articaine 4% epinephrine in United States?

Implantology Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.